BNP Paribas Financial Markets’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $64M | Sell |
328,330
-12,593
| -4% | -$2.61M | 0.02% | 639 |
|
|
2026
Q1 | $76.5M | Buy |
340,923
+57,096
| +20% | +$14.2M | 0.04% | 496 |
|
|
2025
Q4 | $68.4M | Buy |
283,827
+127,139
| +81% | +$32.5M | 0.03% | 547 |
|
|
2025
Q3 | $42.9M | Sell |
156,688
-193,729
| -55% | -$52.9M | 0.02% | 698 |
|
|
2025
Q2 | $90.4M | Buy |
350,417
+40,399
| +13% | +$9.64M | 0.05% | 357 |
|
|
2025
Q1 | $69.4M | Buy |
310,018
+35,601
| +13% | +$8.31M | 0.04% | 474 |
|
|
2024
Q4 | $62.8M | Buy |
274,417
+104,581
| +62% | +$25.2M | 0.04% | 525 |
|
|
2024
Q3 | $41.5M | Sell |
169,836
-68,447
| -29% | -$15.3M | 0.03% | 573 |
|
|
2024
Q2 | $45.6M | Buy |
238,283
+128,402
| +117% | +$26.1M | 0.04% | 447 |
|
|
2024
Q1 | $21.8M | Buy |
109,881
+37,175
| +51% | +$6.81M | 0.02% | 732 |
|
|
2023
Q4 | $12.5M | Sell |
72,706
-11,974
| -14% | -$1.84M | 0.01% | 920 |
|
|
2023
Q3 | $12.5M | Buy |
84,680
+38,900
| +85% | +$7.03M | 0.02% | 800 |
|
|
2023
Q2 | $10M | Sell |
45,780
-102,796
| -69% | -$22.9M | 0.01% | 917 |
|
|
2023
Q1 | $32.5M | Buy |
148,576
+34,415
| +30% | +$7.47M | 0.05% | 419 |
|
|
2022
Q4 | $23.8M | Buy |
114,161
+92,722
| +432% | +$20.4M | 0.04% | 582 |
|
|
2022
Q3 | $4.68M | Sell |
21,439
-1,523
| -7% | -$347K | 0.01% | 1398 |
|
|
2022
Q2 | $4.81M | Sell |
22,962
-929
| -4% | -$198K | 0.01% | 1252 |
|
|
2022
Q1 | $5.79M | Sell |
23,891
-13,203
| -36% | -$3.19M | 0.01% | 1220 |
|
|
2021
Q4 | $9.66M | Buy |
37,094
+2,062
| +6% | +$535K | 0.01% | 974 |
|
|
2021
Q3 | $9.23M | Buy |
35,032
+654
| +2% | +$179K | 0.01% | 985 |
|
|
2021
Q2 | $8.47M | Sell |
34,378
-6,494
| -16% | -$1.37M | 0.01% | 1021 |
|
|
2021
Q1 | $7.93M | Sell |
40,872
-42,898
| -51% | -$8.6M | 0.01% | 926 |
|
|
2020
Q4 | $17.8M | Sell |
83,770
-64,223
| -43% | -$12.8M | 0.03% | 547 |
|
|
2020
Q3 | $25.4M | Sell |
147,993
-28,216
| -16% | -$5.21M | 0.04% | 445 |
|
|
2020
Q2 | $33.8M | Buy |
176,209
+58,693
| +50% | +$9.6M | 0.06% | 304 |
|
|
2020
Q1 | $17.3M | Sell |
117,516
-60,650
| -34% | -$9.66M | 0.04% | 457 |
|
|
2019
Q4 | $27.6M | Buy |
178,166
+153,231
| +615% | +$22.1M | 0.05% | 396 |
|
|
2019
Q3 | $3.37M | Sell |
24,935
-8,757
| -26% | -$1.15M | 0.01% | 1250 |
|
|
2019
Q2 | $4.11M | Buy |
33,692
+3,771
| +13% | +$418K | 0.01% | 1123 |
|
|
2019
Q1 | $3.11M | Sell |
29,921
-2,967
| -9% | -$306K | 0.01% | 1203 |
|
|
2018
Q4 | $3.74M | Sell |
32,888
-87,297
| -73% | -$9.35M | 0.01% | 1043 |
|
|
2018
Q3 | $13.9M | Buy |
120,185
+60,981
| +103% | +$6.68M | 0.02% | 691 |
|
|
2018
Q2 | $6.13M | Sell |
59,204
-7,219
| -11% | -$730K | 0.01% | 1000 |
|
|
2018
Q1 | $6.54M | Buy |
66,423
+12,438
| +23% | +$1.18M | 0.01% | 877 |
|
|
2017
Q4 | $4.57M | Sell |
53,985
-48,902
| -48% | -$4.04M | 0.01% | 1072 |
|
|
2017
Q3 | $7.92M | Buy |
102,887
+24,785
| +32% | +$1.9M | 0.02% | 660 |
|
|
2017
Q2 | $6.08M | Buy |
78,102
+28,801
| +58% | +$2.06M | 0.02% | 691 |
|
|
2017
Q1 | $3.55M | Buy |
49,301
+3,148
| +7% | +$218K | 0.01% | 874 |
|
|
2016
Q4 | $2.86M | Buy |
46,153
+28,973
| +169% | +$1.77M | 0.01% | 785 |
|
|
2016
Q3 | $1.11M | Sell |
17,180
-48,252
| -74% | -$3.21M | ﹤0.01% | 894 |
|
|
2016
Q2 | $4.14M | Sell |
65,432
-19,415
| -23% | -$1.14M | 0.02% | 541 |
|
|
2016
Q1 | $4.91M | Buy |
84,847
+75,951
| +854% | +$4.3M | 0.02% | 568 |
|
|
2015
Q4 | $478K | Sell |
8,896
-16,185
| -65% | -$912K | ﹤0.01% | 1388 |
|
|
2015
Q3 | $1.28M | Buy |
25,081
+21,077
| +526% | +$1.13M | ﹤0.01% | 972 |
|
|
2015
Q2 | $226K | Sell |
4,004
-3,348
| -46% | -$211K | ﹤0.01% | 1657 |
|
|
2015
Q1 | $528K | Sell |
7,352
-382
| -5% | -$24.8K | ﹤0.01% | 1297 |
|
|
2014
Q4 | $434K | Sell |
7,734
-10,470
| -58% | -$547K | ﹤0.01% | 1167 |
|
|
2014
Q3 | $897K | Buy |
18,204
+8,773
| +93% | +$447K | ﹤0.01% | 1291 |
|
|
2014
Q2 | $477K | Sell |
9,431
-14,960
| -61% | -$741K | ﹤0.01% | 1510 |
|
|
2014
Q1 | $1.22M | Buy |
24,391
+9,296
| +62% | +$418K | ﹤0.01% | 1084 |
|
|
2013
Q4 | $711K | Sell |
15,095
-170
| -1% | -$8.61K | ﹤0.01% | 1148 |
|
|
2013
Q3 | $806K | Sell |
15,265
-649
| -4% | -$31.5K | ﹤0.01% | 1238 |
|
|
2013
Q2 | $718K | Buy |
+15,914
| New | +$755K | ﹤0.01% | 1249 |
|
Other funds holding RMD
VCM
VPM
BNP Paribas Financial Markets's RMD Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its ResMed (RMD) stake by 3.7% in Q2 2026, selling an estimated $2.61M and leaving 328,330 shares worth $64M. The position accounts for 0.02% of the portfolio, ranked #639.
BNP Paribas Financial Markets first reported a position in RMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $90.4M in Q2 2025. 707 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- BNP Paribas Financial Markets held 328,330 shares of ResMed worth $64M as of Q2 2026.
- BNP Paribas Financial Markets sold 12,593 ResMed shares in Q2 2026, an estimated $2.61M.
- ResMed made up 0.02% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #639 holding.
- BNP Paribas Financial Markets first reported a position in ResMed in Q2 2013 and has held it in 53 quarters since.
- BNP Paribas Financial Markets's ResMed position peaked at $90.4M in Q2 2025.
- 707 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.